Article info

PDF

Assessment of industry data on pulmonary and immunosuppressive effects of IQOS

Authors

  1. Correspondence to Dr Farzad Moazed, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA; farzad.moazed{at}ucsf.edu
View Full Text

Citation

Moazed F, Chun L, Matthay MA, et al
Assessment of industry data on pulmonary and immunosuppressive effects of IQOS

Publication history

  • Received February 6, 2018
  • Revised July 19, 2018
  • Accepted July 20, 2018
  • First published August 29, 2018.
Online issue publication 
October 22, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.